HK Stock MarketDetailed Quotes

01358 PW MEDTECH

Watchlist
  • 1.010
  • -0.030-2.88%
Market Closed Nov 15 16:08 CST
1.51BMarket Cap9.10P/E (TTM)

PW MEDTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
6.08%338.42M
25.75%675.08M
48.90%319.02M
97.80%536.83M
60.50%214.25M
9.72%271.4M
31.47%133.49M
-31.71%247.35M
-41.07%101.54M
16.53%362.18M
Operating income
6.08%338.42M
25.75%675.08M
48.90%319.02M
97.80%536.83M
60.50%214.25M
9.72%271.4M
31.47%133.49M
-31.71%247.35M
-41.07%101.54M
16.53%362.18M
Cost of sales
-6.03%-150.8M
-23.61%-294.19M
-52.66%-142.22M
-125.93%-238M
-82.62%-93.16M
-6.68%-105.34M
-21.39%-51.01M
29.49%-98.75M
36.07%-42.02M
-21.19%-140.06M
Operating expenses
-6.03%-150.8M
-23.61%-294.19M
-52.66%-142.22M
-125.93%-238M
-82.62%-93.16M
-6.68%-105.34M
-21.39%-51.01M
29.49%-98.75M
36.07%-42.02M
-21.19%-140.06M
Gross profit
6.12%187.62M
27.46%380.9M
46.01%176.8M
79.95%298.83M
46.81%121.09M
11.74%166.06M
38.59%82.48M
-33.10%148.6M
-44.16%59.51M
13.77%222.13M
Selling expenses
-1.78%-39.92M
-12.77%-76.09M
-9.42%-39.22M
-9.21%-67.47M
-5.26%-35.84M
25.27%-61.78M
26.80%-34.05M
18.28%-82.67M
7.37%-46.52M
-38.73%-101.16M
Administrative expenses
-0.79%-60.27M
6.21%-119.02M
-30.29%-59.8M
-94.55%-126.9M
-70.49%-45.9M
-15.35%-65.23M
18.70%-26.92M
13.33%-56.55M
-7.51%-33.11M
-12.32%-65.24M
Research and development expenses
10.35%-20.6M
-0.38%-41.13M
-67.79%-22.97M
-102.32%-40.98M
-85.88%-13.69M
55.75%-20.25M
31.12%-7.37M
-79.38%-45.77M
-9.33%-10.69M
5.17%-25.51M
Profit from asset sales
----
---6.1M
----
----
----
24.51%731.75M
--731.75M
--587.72M
----
----
Revaluation surplus
-97.51%-397K
75.60%-61K
84.44%-201K
97.90%-250K
4.30%-1.29M
-578.84%-11.9M
90.35%-1.35M
-6.24%-1.75M
-2,690.19%-13.99M
---1.65M
-Changes in the fair value of investment property
-97.51%-397K
75.60%-61K
84.44%-201K
97.90%-250K
4.30%-1.29M
-578.84%-11.9M
90.35%-1.35M
-6.24%-1.75M
-2,690.19%-13.99M
---1.65M
Impairment and provision
----
----
----
----
----
-316.45%-40.69M
35.48%-4.09M
36.95%-9.77M
-32.08%-6.34M
-210.07%-15.5M
-Impairment of property, machinery and equipment
----
----
----
----
----
---40.69M
----
----
----
----
-Other impairment is provision
----
----
----
----
----
----
35.48%-4.09M
36.95%-9.77M
-32.08%-6.34M
-210.07%-15.5M
Special items of operating profit
-46.12%18.07M
-17.98%48.9M
-20.63%33.54M
446.14%59.61M
868.98%42.26M
19.89%-17.22M
-104.72%-5.5M
-88.61%-21.5M
6,238.62%116.51M
42.24%-11.4M
Operating profit
-4.13%84.51M
52.55%187.4M
32.30%88.15M
-81.95%122.84M
-90.93%66.63M
31.34%680.73M
1,024.37%734.95M
30,918.25%518.32M
580.05%65.37M
-94.73%1.67M
Financing income
37.18%27.79M
25.12%43.67M
53.90%20.26M
-38.47%34.9M
--13.16M
1,206.71%56.73M
----
---5.13M
----
----
Financing cost
----
----
----
----
----
----
433.34%30.89M
----
36.81%-9.27M
-388.74%-28.68M
Share of profits of associates
----
----
----
----
----
----
----
0.52%113.41M
17.41%79.08M
11.97%112.82M
Earning before tax
3.59%112.3M
46.48%231.07M
35.86%108.41M
-78.61%157.75M
-89.58%79.79M
17.69%737.46M
466.52%765.84M
630.23%626.6M
116.98%135.18M
-32.21%85.81M
Tax
-61.79%-18.66M
9.82%-26.04M
-38.83%-11.54M
-1,847.13%-28.88M
-74.74%-8.31M
-68.28%1.65M
-179.67%-4.76M
235.76%5.21M
344.49%5.97M
65.30%-3.84M
After-tax profit from continuing operations
-3.34%93.64M
59.10%205.02M
35.52%96.87M
-82.56%128.87M
-90.61%71.49M
16.98%739.12M
439.20%761.09M
670.79%631.81M
135.80%141.15M
-29.04%81.97M
Earning after tax
-3.34%93.64M
59.10%205.02M
35.52%96.87M
-82.56%128.87M
-90.61%71.49M
16.98%739.12M
439.20%761.09M
670.79%631.81M
135.80%141.15M
-95.08%81.97M
Minority profit
-9.56%23.42M
127.11%51.84M
138.53%25.9M
760,966.67%22.83M
542,950.00%10.86M
0.00%-3K
0.00%-2K
76.92%-3K
77.78%-2K
-101.86%-13K
Profit attributable to shareholders
-1.07%70.22M
44.46%153.18M
17.07%70.98M
-85.65%106.04M
-92.03%60.63M
16.98%739.12M
439.20%761.09M
670.67%631.81M
135.77%141.15M
-95.08%81.98M
Basic earnings per share
-0.88%0.0449
44.46%0.0978
17.05%0.0453
-85.63%0.0677
-92.02%0.0387
16.99%0.471
439.49%0.485
671.26%0.4026
135.34%0.0899
-95.08%0.0522
Diluted earnings per share
-0.88%0.0449
44.46%0.0978
17.05%0.0453
-85.63%0.0677
-92.02%0.0387
16.99%0.471
439.49%0.485
671.26%0.4026
135.34%0.0899
-95.08%0.0522
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 6.08%338.42M25.75%675.08M48.90%319.02M97.80%536.83M60.50%214.25M9.72%271.4M31.47%133.49M-31.71%247.35M-41.07%101.54M16.53%362.18M
Operating income 6.08%338.42M25.75%675.08M48.90%319.02M97.80%536.83M60.50%214.25M9.72%271.4M31.47%133.49M-31.71%247.35M-41.07%101.54M16.53%362.18M
Cost of sales -6.03%-150.8M-23.61%-294.19M-52.66%-142.22M-125.93%-238M-82.62%-93.16M-6.68%-105.34M-21.39%-51.01M29.49%-98.75M36.07%-42.02M-21.19%-140.06M
Operating expenses -6.03%-150.8M-23.61%-294.19M-52.66%-142.22M-125.93%-238M-82.62%-93.16M-6.68%-105.34M-21.39%-51.01M29.49%-98.75M36.07%-42.02M-21.19%-140.06M
Gross profit 6.12%187.62M27.46%380.9M46.01%176.8M79.95%298.83M46.81%121.09M11.74%166.06M38.59%82.48M-33.10%148.6M-44.16%59.51M13.77%222.13M
Selling expenses -1.78%-39.92M-12.77%-76.09M-9.42%-39.22M-9.21%-67.47M-5.26%-35.84M25.27%-61.78M26.80%-34.05M18.28%-82.67M7.37%-46.52M-38.73%-101.16M
Administrative expenses -0.79%-60.27M6.21%-119.02M-30.29%-59.8M-94.55%-126.9M-70.49%-45.9M-15.35%-65.23M18.70%-26.92M13.33%-56.55M-7.51%-33.11M-12.32%-65.24M
Research and development expenses 10.35%-20.6M-0.38%-41.13M-67.79%-22.97M-102.32%-40.98M-85.88%-13.69M55.75%-20.25M31.12%-7.37M-79.38%-45.77M-9.33%-10.69M5.17%-25.51M
Profit from asset sales -------6.1M------------24.51%731.75M--731.75M--587.72M--------
Revaluation surplus -97.51%-397K75.60%-61K84.44%-201K97.90%-250K4.30%-1.29M-578.84%-11.9M90.35%-1.35M-6.24%-1.75M-2,690.19%-13.99M---1.65M
-Changes in the fair value of investment property -97.51%-397K75.60%-61K84.44%-201K97.90%-250K4.30%-1.29M-578.84%-11.9M90.35%-1.35M-6.24%-1.75M-2,690.19%-13.99M---1.65M
Impairment and provision ---------------------316.45%-40.69M35.48%-4.09M36.95%-9.77M-32.08%-6.34M-210.07%-15.5M
-Impairment of property, machinery and equipment -----------------------40.69M----------------
-Other impairment is provision ------------------------35.48%-4.09M36.95%-9.77M-32.08%-6.34M-210.07%-15.5M
Special items of operating profit -46.12%18.07M-17.98%48.9M-20.63%33.54M446.14%59.61M868.98%42.26M19.89%-17.22M-104.72%-5.5M-88.61%-21.5M6,238.62%116.51M42.24%-11.4M
Operating profit -4.13%84.51M52.55%187.4M32.30%88.15M-81.95%122.84M-90.93%66.63M31.34%680.73M1,024.37%734.95M30,918.25%518.32M580.05%65.37M-94.73%1.67M
Financing income 37.18%27.79M25.12%43.67M53.90%20.26M-38.47%34.9M--13.16M1,206.71%56.73M-------5.13M--------
Financing cost ------------------------433.34%30.89M----36.81%-9.27M-388.74%-28.68M
Share of profits of associates ----------------------------0.52%113.41M17.41%79.08M11.97%112.82M
Earning before tax 3.59%112.3M46.48%231.07M35.86%108.41M-78.61%157.75M-89.58%79.79M17.69%737.46M466.52%765.84M630.23%626.6M116.98%135.18M-32.21%85.81M
Tax -61.79%-18.66M9.82%-26.04M-38.83%-11.54M-1,847.13%-28.88M-74.74%-8.31M-68.28%1.65M-179.67%-4.76M235.76%5.21M344.49%5.97M65.30%-3.84M
After-tax profit from continuing operations -3.34%93.64M59.10%205.02M35.52%96.87M-82.56%128.87M-90.61%71.49M16.98%739.12M439.20%761.09M670.79%631.81M135.80%141.15M-29.04%81.97M
Earning after tax -3.34%93.64M59.10%205.02M35.52%96.87M-82.56%128.87M-90.61%71.49M16.98%739.12M439.20%761.09M670.79%631.81M135.80%141.15M-95.08%81.97M
Minority profit -9.56%23.42M127.11%51.84M138.53%25.9M760,966.67%22.83M542,950.00%10.86M0.00%-3K0.00%-2K76.92%-3K77.78%-2K-101.86%-13K
Profit attributable to shareholders -1.07%70.22M44.46%153.18M17.07%70.98M-85.65%106.04M-92.03%60.63M16.98%739.12M439.20%761.09M670.67%631.81M135.77%141.15M-95.08%81.98M
Basic earnings per share -0.88%0.044944.46%0.097817.05%0.0453-85.63%0.0677-92.02%0.038716.99%0.471439.49%0.485671.26%0.4026135.34%0.0899-95.08%0.0522
Diluted earnings per share -0.88%0.044944.46%0.097817.05%0.0453-85.63%0.0677-92.02%0.038716.99%0.471439.49%0.485671.26%0.4026135.34%0.0899-95.08%0.0522
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data